EYED PHARMA
People
14
Locations
1
Publications
19
Company Profile
Founded Date
December 20, 2012
Last Balance Sheet Year
2024
Juridical Form
Naamloze vennootschap
Enterprise Type
Rechtspersoon
Activity
72101 - Speur- en ontwikkelingswerk op biotechnologisch gebied
Company Age
14 years
Contact Details
Unlock direct contact points, registry address detail, and website links for EYED PHARMA.
Unlock Contact Details
Reveal email, phone, website, and full registry contact information.
Create Free AccountHistorical Financials
| KPI | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | €11,761,713 | - | - |
| Gross Margin | €254,123 (-76.9%) | €1,100,047 (+0.7%) | €1,092,560 (-14.5%) |
| Profit | -€6,940,910 (-15.0%) | -€6,034,167 (+4.4%) | -€6,310,755 (-34.7%) |
| EBITDA | -€2,857,855 (-32.0%) | -€2,165,631 (+43.6%) | -€3,841,397 (-28.2%) |
| Equity | €22,782,731 (-17.2%) | €27,522,992 (+68.9%) | €16,296,064 (-19.5%) |
| Debt | €19,541,290 (+89.2%) | €10,330,687 (-4.1%) | €10,772,915 (-13.5%) |
| Total Assets | €42,332,692 (+11.8%) | €37,866,006 (+39.7%) | €27,109,357 (-17.2%) |
| Cash | €1,214,166 (+17.5%) | €1,033,545 (-70.2%) | €3,473,979 (-74.3%) |
| FTE | 33.5 (-18.5%) | 41.1 (+4.8%) | 39.2 (+22.5%) |
Unlock Full History
Create a free account to access up to 10 years of historical financial data for EYED PHARMA.
Create Free AccountFinancial Health
Ratio-level insight derived from the latest company and balance sheet data.
Current Ratio
1.3x
(-42.6%)
Quick Ratio
1.3x
(-39.8%)
Solvency
53.8%
(-26.0%)
Debt / Equity
0.9x
Unlock Advanced Metrics
Access the full ratio deck, benchmarking signals, and deeper profitability diagnostics.
Create Free AccountLocations & Footprint
Establishment
AddressRue Louis Plescia 9, 4102 Seraing, Belgium
Entity Network
First-level relations linked directly to EYED PHARMA. Unlock second-level relations for deeper graph exploration.
EYED PHARMA
Active
- BIOWIN
Outgoing link
Administrator Legal - CORPAR
Incoming link
Administrator Legal - Fund+
Incoming link
Administrator Legal - NOSHAQ
Incoming link
Administrator Legal - OUKELOS
Incoming link
Administrator Legal - Qbic Venture Partners II
Incoming link
Administrator Legal - SPARAXIS
Incoming link
Administrator Legal -
Carolyn Myers
Incoming link
Administrator Natural -
Denis Knoops
Incoming link
Administrator Natural -
Jean Marie Rakic
Incoming link
Administrator Natural -
Marc Foidart
Incoming link
Administrator Natural - Fund+
Outgoing link
Participating Interest - Ophtalmologie Chirurgicale Van Cauwenberge Rakic
Outgoing link
Participating Interest - OUSIA
Outgoing link
Participating Interest - QBIC II FUND ARKIV
Outgoing link
Participating Interest - WTW AG
Outgoing link
Participating Interest -
Bart De Leeuw
Incoming link
Administrator Legal Representative -
Baudouin Jolly
Incoming link
Administrator Legal Representative -
Caroline Thielen
Incoming link
Administrator Legal Representative -
Chris BUYSE
Incoming link
Administrator Legal Representative -
Eric Brandt
Incoming link
Administrator Legal Representative -
François Meurgey
Incoming link
Administrator Legal Representative -
Jean Van Nuwenborg
Incoming link
Administrator Legal Representative -
Lawrence Van Helleputte
Incoming link
Administrator Legal Representative -
Sofie BAETEN
Incoming link
Administrator Legal Representative
Unlock Second-Level Relations
Expand beyond direct links to see second-level entities, people, and cross-company paths.
Free Sign UpManagement & Key People
Unlock linked people, governance roles, and enriched demographic signals associated with EYED PHARMA.
Management Profiles
Unlock directors, managers, role history, plus inferred gender and age where available.
Create Free Account